BackInnoCan Pharma Overview

InnoCan Pharma Receivables

Track InnoCan Pharma's receivables ($1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.00M
↑ 37.37% YoYΔ $272795.00 vs prior year quarter

Peer trimmed avg / median

Loading

InnoCan Pharma Receivables History

Loading

InnoCan Pharma vs. peers: Receivables Comparison

Loading

InnoCan Pharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

InnoCan Pharma (INNPF) FAQ

InnoCan Pharma (INNPF) currently reports a receivables of $1M as of June 2026. That compares with $730K in the prior-year period — up 37.4% year over year. Use the charts on this page to explore InnoCan Pharma's receivables history and peer comparisons.

InnoCan Pharma's receivables increased from $730K to $1M — a 37.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

InnoCan Pharma reported $1M in receivables as of June 2026. That compares with $730K in the prior-year period — up 37.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for InnoCan Pharma, and consider following INNPF for alerts when major investors trade the stock.

Questions & Answers